response

Warmth in Action: Web3 & FinTech Industry’s Dual-Pronged Response to Hong Kong’s Tai Po Fire

HONG KONG, Dec. 4, 2025 /PRNewswire/ -- Following the fire at Tai Po Hong Fuk Yuen on November 26, the Web3…

17 hours ago

4D Paths Physics-Inspired QPOR Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial

NEWTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel,…

3 days ago

Burn Blend Releases Comprehensive Gelatin Trick Recipe Based Protocol Guide in Response to Rising Public Interest in Weight-Management Methods

New York City, NY, Nov. 23, 2025 (GLOBE NEWSWIRE) --  The organization Burn Blend has released a series of guidelines…

2 weeks ago

ECW Announces US$3.5 Million First Emergency Response Grant in Bangladesh

Delivered by UNICEF with a broad consortium of local partners, the new grant will restore education for 180,000 children NEW…

4 weeks ago

BlueWillow Biologics Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications

ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of…

4 weeks ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

 Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroups Berlin, Germany, October 18, 2025…

2 months ago

Saksoft to Showcase ‘SakCare’ – AI-Powered Critical Service Response Solution for BFS at Dreamforce 2025

BENGALURU, India, Oct. 9, 2025 /PRNewswire/ -- Saksoft, a leader in digital transformation, will unveil SakCare, an AI-powered customer care…

2 months ago

BYD improves Assisted Driving system in response to Euro NCAPs ATTO 3 grading

LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which Euro NCAP gave to the ATTO 3’s Assisted…

2 months ago

AV-Comparatives Publishes 2025 Endpoint Prevention & Response (EPR) Test – The Most Comprehensive Enterprise Cybersecurity Evaluation to Date

INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its…

2 months ago